PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan, leveraging deep expertise and proven scientific principles to deliver new biologics in hematology, oncology, and immunology. Founded in 2003, PharmaEssentia is now expanding its global presence with operations in the U.S., Japan, China and Korea.
-
Industry
-
Biotechnology Research
-
Company size
-
201-500 employees
-
Headquarters
-
Burlington, MA
-
Type
-
Public Company
-
Founded
-
2003
-
Specialties
-
Biologics, Oncology, Rare Disease, Orphan Drugs, Orphan Disease, Drug Development, Pharmaceuticals, and Hematology